[Retracted] Investigating the Effects of Dapagliflozin on Cardiac Function, Inflammatory Response, and Cardiovascular Outcome in Patients with STEMI Complicated with T2DM after PCI

Table 4

Comparison of inflammatory response levels before and after treatment (n, ±s).

Index	Time	Control group (n = 35)	Observation group (n = 35)	t value	P value
MPO (ng/ml)	Before therapy	28.13 ± 5.46	28.01 ± 5.68	0.090	0.929
	After treatment	19.93 ± 4.39	11.86 ± 4.69	7.867	≤0.001
CRP (ug/ml)	Before therapy	14.81 ± 3.25	14.93 ± 3.16	0.157	0.876
	After treatment	8.31 ± 2.78	4.39 ± 1.81	6.991	≤0.001
IL-6 (pg/ml)	Before therapy	17.63 ± 3.36	19.06 ± 3.74	1.683	0.097
	After treatment	12.77 ± 2.83	7.02 ± 2.93	8.351	≤0.001
TNF-α (pg/ml)	Before therapy	31.23 ± 5.83	32.44 ± 5.17	0.919	0.362
	After treatment	23.27 ± 5.42	14.06 ± 4.51	7.728	≤0.001